IV Opioids in the Hospital: A Controversial Lifeline for Patients in Fentanyl Withdrawal
A new viewpoint in the Journal of General Internal Medicine argues that intravenous opioids should be recognized as a legitimate, ...
A new viewpoint in the Journal of General Internal Medicine argues that intravenous opioids should be recognized as a legitimate, ...
A multi-state analysis of Medicaid claims shows Black and Hispanic patients are significantly less likely to fill and stay on ...
A rat study using advanced mass spectrometry shows chronic morphine shifts brain lipid profiles toward sphingolipid enrichment, while buprenorphine treatment ...
A qualitative study of 28 recently incarcerated adults shows that stigma, transportation, clinic rules and the fentanyl supply shape whether ...
A qualitative study of the Rhode Island Department of Corrections finds that medications for opioid use disorder can reduce contraband ...
A new review argues that Brixadi, an extended-release injectable buprenorphine approved for opioid use disorder, warrants clinical investigation as a ...
Targeted educational videos featuring a rural physician's experience with buprenorphine significantly reduced perceived barriers and increased primary care practitioners' intention ...
A retrospective chart review from Vancouver General Hospital found that a novel symptom-inhibited fentanyl induction protocol caused no serious adverse ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine